Topical tofacitinib safe and effective for treatment of refractory vitiligo
Home Page | XELJANZ® (tofacitinib) | Safety Info
A pilot study of 2% tofacitinib cream with narrowband ultraviolet B for the treatment of facial vitiligo - Journal of the American Academy of Dermatology
Alopecia World on Twitter: "Xeljanz (Tofacitinib Citrate): An Alopecia World member's experience on the trial https://t.co/tMFeI9isnn" / Twitter
FDA holds back from action over Xeljanz safety study -
Tofacitinib shows promise in PsA trials | Nature Reviews Rheumatology
Alopecia Treatment Update on JAK Inhibitors Ruxolitinib and Tofacitinib
Alopecia Treatment Update on JAK Inhibitors Ruxolitinib and Tofacitinib
Treatment of atopic dermatitis with ruxolitinib cream (JAK1/JAK2 inhibitor) or triamcinolone cream - ScienceDirect
Successful Treatment of Severe Alopecia Areata With Oral or Topical Tofacitinib - JDDonline - Journal of Drugs in Dermatology
Tofacitinib in Alopecia Areata - CareFirst Specialty Pharmacy's Blog
Home Page | XELJANZ® (tofacitinib) | Safety Info
Tofacitinib Cream for Treatment of Vitiligo - CareFirst Specialty Pharmacy's Blog
Vitiligo Treatment Options - Chemistry Rx
Tofacitinib and Ruxolitinib - American Chemical Society